Brief: Iteos Therapeutics QTRLY Net Income Of $0.16 Per Basic Share And $ 0.15 Per Diluted Share
10/08/2022 21:57
Iteos Therapeutics Inc ITOS.O :
* ITEOS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
* QTRLY NET INCOME OF $0.16 PER BASIC SHARE AND $ 0.15 PER
DILUTED
SHARE
* Q2 EARNINGS PER SHARE VIEW $1.20 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX2Rhjb2
Further company coverage: ITOS.O
Recent news on iTeos Therapeutics
See all newsIteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive